Xiaofang Pharmaceutical released its 2026 semi-annual report on the evening of August 26. In the first half, it achieved attributable net profit of about 106 million yuan, down 12.64% year-on-year. In the same period, the company achieved operating revenue of about 282 million yuan, up 4.5% year-on-year. Xiaofang Pharmaceutical mainly focuses on the field of topical drugs, with products primarily over-the-counter medicines. The company said the fluctuation in net profit was mainly affected by factors such as rising raw material costs, strengthening the sales team, and brand promotion through online channels.
XIAO FANG ORD A (SHH) EQSW Exp:Attributable net profit fell 12.64% year-on-year in H1 2026.
